JP2010024207A - Liquid cosmetic filled in spray container - Google Patents
Liquid cosmetic filled in spray container Download PDFInfo
- Publication number
- JP2010024207A JP2010024207A JP2008190210A JP2008190210A JP2010024207A JP 2010024207 A JP2010024207 A JP 2010024207A JP 2008190210 A JP2008190210 A JP 2008190210A JP 2008190210 A JP2008190210 A JP 2008190210A JP 2010024207 A JP2010024207 A JP 2010024207A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- hyaluronic acid
- container
- liquid cosmetic
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 42
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 239000007921 spray Substances 0.000 title abstract description 20
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 91
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 91
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 91
- 150000003839 salts Chemical class 0.000 claims abstract description 88
- 125000001453 quaternary ammonium group Chemical group 0.000 claims abstract description 20
- 238000005507 spraying Methods 0.000 claims description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 5
- 150000001450 anions Chemical class 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- 239000002994 raw material Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000003595 mist Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 229940010747 sodium hyaluronate Drugs 0.000 description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000010908 decantation Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- -1 polyoxyethylene Polymers 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000002016 disaccharides Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 210000000474 heel Anatomy 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229920004900 octoxynol-3 Polymers 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、特定のカチオン化度を有するカチオン化ヒアルロン酸及び/又はその塩を配合した噴霧用容器からの噴霧性に優れた液状化粧料に関する。 The present invention relates to a liquid cosmetic excellent in sprayability from a container for spraying containing a cationized hyaluronic acid having a specific degree of cationization and / or a salt thereof.
ヒアルロン酸及び/又はその塩は、生体、特に皮下組織に存在するムコ多糖類であり、その高い保水機能等により化粧料の原料として広く利用されている。 Hyaluronic acid and / or a salt thereof is a mucopolysaccharide present in living bodies, particularly subcutaneous tissues, and is widely used as a raw material for cosmetics due to its high water retention function and the like.
また、ヒアルロン酸及び/又はその塩を配合した化粧料の使用部位は、毛髪、顔、唇、手足、肘、膝、踵等全身であり、使用部位に応じて、液状(例えば、化粧水、液状ファンデーション、美白美容液、ボディローション、サンローション)、半固体状(例えば、ヘアクリーム、バニシングクリーム、シャンプー、保湿パック)、シート状(例えば、保湿シート)、固形状(例えば、リップクリーム、パウダーファンデーション)等様々な剤型を取っている。 Further, the use site of the cosmetic containing hyaluronic acid and / or a salt thereof is the whole body such as hair, face, lips, limbs, elbows, knees, heels, etc., and depending on the use site, it is liquid (for example, lotion, Liquid foundation, whitening serum, body lotion, sun lotion), semi-solid (for example, hair cream, burnishing cream, shampoo, moisturizing pack), sheet (for example, moisturizing sheet), solid (for example, lip balm, powder) Various dosage forms such as foundation).
様々な剤型のヒアルロン酸及び/又はその塩を配合した化粧料のうち、ヒアルロン酸及び/又はその塩を配合した液状化粧料を噴霧用容器から噴霧することができれば、ヒアルロン酸及び/又はその塩を毛髪や顔等に簡便に万遍なく行き渡らせることによる優れた使用感を期待できる。しかしながら、液状化粧料にヒアルロン酸及び/又はその塩を配合した場合、噴霧用容器から噴射する際、霧状にならず液滴状に噴射され使用感を損ねた。 Of the cosmetics containing hyaluronic acid and / or salts thereof in various dosage forms, if liquid cosmetics containing hyaluronic acid and / or salts thereof can be sprayed from the container for spraying, hyaluronic acid and / or its An excellent feeling of use can be expected by spreading the salt on the hair and face easily and universally. However, when hyaluronic acid and / or a salt thereof is blended in a liquid cosmetic, when it is sprayed from a spray container, it is sprayed in the form of droplets rather than in the form of a mist and the usability is impaired.
例えば、特開平5−170641号公報(特許文献1)には、保湿剤として、1,3−ブチレングリコ−ル,ポリエチレングリコ−ル,マルチト−ル,ソルビトール,フルクトース,グルコース,ポリオキシエチレンメチルグルコシド,ヒアルロン酸もしくはその塩の1種又は2種以上を配合し、浸透圧が200〜600ミリオスモルである化粧料が記載されている。特開平6−65050号公報(特許文献2)には、ヒアルロン酸及び/又はその塩と、ドコサヘキサエン酸又はその塩もしくはエステルとを配合する皮膚外用剤が記載されている。
しかしながら、従来、ヒアルロン酸及び/又はその塩を噴霧用容器から噴霧させる際に生ずる特有の問題点を解決する手段については何ら開示されていない。 However, there is no disclosure of means for solving the specific problems that occur when hyaluronic acid and / or a salt thereof is sprayed from a spray container.
本発明の目的は、ヒアルロン酸及び/又はその塩を配合した噴霧用容器詰め液状化粧料であって、噴霧性に優れた噴霧用容器詰め液状化粧料を提供することである。 An object of the present invention is to provide a container-packed liquid cosmetic for spraying containing hyaluronic acid and / or a salt thereof and having excellent sprayability.
本発明者は、上記目的を達成すべく、液状化粧料について鋭意研究を重ねた結果、特定のカチオン化度を有するカチオン化ヒアルロン酸及び/又はその塩を配合せしめるならば、意外にも、噴霧用容器からの噴霧性に優れた液状化粧料が得られることを見出し、本発明を完成するに至った。 As a result of intensive research on liquid cosmetics to achieve the above object, the present inventor unexpectedly sprayed cationized hyaluronic acid and / or a salt thereof having a specific cationization degree. The present inventors have found that a liquid cosmetic excellent in sprayability from a container for use can be obtained, thereby completing the present invention.
すなわち、本発明は、
(1)第四級アンモニウム基含有基を有し、カチオン化度が0.15〜0.6であるヒアルロン酸及び/又はその塩を配合する噴霧用容器詰め液状化粧料、
(2)前記第四級アンモニウム基含有基が、下記一般式(A)で表される請求項1記載の噴霧用容器詰め液状化粧料、
(式中、R1〜R3は独立して炭化水素基を表し、X−は1価の陰イオンを表す。)、
(3)前記カチオン化ヒアルロン酸及び/又はその塩が、下記一般式(B)の繰り返し構成単位で表される(1)又は(2)記載の噴霧用容器詰め液状化粧料、
(式中、R4〜R9は独立して、水素原子又は第四級アンモニウム基含有基を表す。ただし、R4〜R9がいずれも水素原子を表す場合を除く。)、
である。
That is, the present invention
(1) A containerized liquid cosmetic for spraying containing a quaternary ammonium group-containing group and a hyaluronic acid having a cationization degree of 0.15 to 0.6 and / or a salt thereof,
(2) The container-packed liquid cosmetic for spraying according to claim 1, wherein the quaternary ammonium group-containing group is represented by the following general formula (A):
(Wherein R 1 to R 3 independently represent a hydrocarbon group, and X − represents a monovalent anion).
(3) The containerized liquid cosmetic for spraying according to (1) or (2), wherein the cationized hyaluronic acid and / or salt thereof is represented by a repeating structural unit of the following general formula (B):
(In the formula, R 4 to R 9 independently represent a hydrogen atom or a quaternary ammonium group-containing group, except that R 4 to R 9 all represent a hydrogen atom).
It is.
本発明によれば、第四級アンモニウム基含有基を有し、特定のカチオン化度を有するカチオン化ヒアルロン酸及び/又はその塩を配合せしめることにより、噴霧用容器からの噴霧性に優れた液状化粧料を提供することができる。したがって、ヒアルロン酸及び/又はその塩を毛髪や顔等に簡便に万遍なく行き渡らせることによる優れた使用感を期待できることから、ヒアルロン酸及び/又はその塩の更なる利用拡大が期待できる。 According to the present invention, a liquid that has a quaternary ammonium group-containing group and is excellent in sprayability from a container for spraying by incorporating a cationized hyaluronic acid having a specific cationization degree and / or a salt thereof. Cosmetics can be provided. Therefore, since it is possible to expect an excellent feeling of use by easily spreading the hyaluronic acid and / or salt thereof to the hair, the face, etc., further expansion of use of the hyaluronic acid and / or salt thereof can be expected.
以下、本発明の一実施形態に係る噴霧用容器詰め液状化粧料について詳細に説明する。なお、特に規定しない限り「%」は「質量%」を意味する。 Hereinafter, the container-packed liquid cosmetic for spraying according to an embodiment of the present invention will be described in detail. Unless otherwise specified, “%” means “mass%”.
本発明の噴霧用容器詰め液状化粧料は、特定のカチオン化ヒアルロン酸及び/又はその塩を配合することを特徴とする。従って、本発明の本質的部分であるカチオン化ヒアルロン酸及び/又はその塩についてまず詳述する。 The containerized liquid cosmetic for spraying of the present invention is characterized by blending a specific cationized hyaluronic acid and / or a salt thereof. Accordingly, the cationized hyaluronic acid and / or salt thereof, which is an essential part of the present invention, will be described in detail first.
「ヒアルロン酸」とは、グルクロン酸とN−アセチルグルコサミンとの二糖からなる繰り返し構成単位を1以上有する多糖類をいう。「第四級アンモニウム基含有基」とは、第四級アンモニウム基を少なくとも一部に有する基である。また、本発明において、ヒアルロン酸及び/又はその塩の「カチオン化度」とは、ヒアルロン酸及び/又はその塩の構成単位である上記二糖当たりの第四級アンモニウム基含有基の数(置換数)をいう。 “Hyaluronic acid” refers to a polysaccharide having one or more repeating structural units composed of disaccharides of glucuronic acid and N-acetylglucosamine. The “quaternary ammonium group-containing group” is a group having a quaternary ammonium group at least partially. In the present invention, “degree of cationization” of hyaluronic acid and / or a salt thereof refers to the number of quaternary ammonium group-containing groups per disaccharide as a constituent unit of hyaluronic acid and / or a salt thereof (substitution Number).
本発明の噴霧用容器詰め液状化粧料に用いるカチオン化ヒアルロン酸及び/又はその塩は、第四級アンモニウム基含有基を有し、かつ、カチオン化度は0.15〜0.6であり、さらに0.2〜0.6であることが好ましい。ヒアルロン酸及び/又はその塩のカチオン化度が前記範囲より低い場合、噴霧用容器から霧状に噴霧し難く、液滴状に噴射してしまう場合がある。カチオン化度が前記範囲を超える場合、健康や美容に関する効果の発現が期待できない場合がある。 The cationized hyaluronic acid and / or salt thereof used for the container-packed liquid cosmetic of the present invention has a quaternary ammonium group-containing group, and the degree of cationization is 0.15 to 0.6. Furthermore, it is preferable that it is 0.2-0.6. When the degree of cationization of hyaluronic acid and / or a salt thereof is lower than the above range, it is difficult to spray from the spray container in the form of a mist and the liquid may be ejected in the form of droplets. When the degree of cationization exceeds the above range, it may not be possible to expect the effects on health and beauty.
本発明の噴霧用容器詰め液状化粧料に用いるカチオン化ヒアルロン酸及び/又はその塩が有する第四級アンモニウム基含有基は、特に限定されないが、下記一般式(A)で表される3−ハロゲノ−2−ヒドロキシプロピルトリアルキルアンモニウムハライドが噴霧性に優れ好ましい。
(式中、R1〜R3は独立して炭化水素基を表し、X−は1価の陰イオンを表す。)
上記一般式(A)において、R1〜R3で表される炭化水素基としては、特に限定されないが、例えば、直鎖状又は分岐状のアルキル基、不飽和炭化水素基、及び芳香族炭化水素基が挙げられ、炭素数1〜6のアルキル基が噴霧性に優れ好ましく、メチル基、エチル基、n−プロピル基、イソプロピル基等の炭素数1〜3のアルキル基がより好ましく、メチル基がさらに好ましい。また、上記一般式(A)において、X−で表される1価の陰イオンとしては、特に限定されないが、例えば、フッ素イオン、臭素イオン、塩素イオン、ヨウ素イオン等のハロゲンイオンが挙げられ、塩素イオンが噴霧性に優れ好ましい。また、カチオン化剤は、単独でも二種以上を組み合わせて使用してもよい。
The quaternized ammonium group-containing group of the cationized hyaluronic acid and / or salt thereof used in the container-packed liquid cosmetic of the present invention is not particularly limited, but 3-halogeno represented by the following general formula (A) -2-Hydroxypropyltrialkylammonium halide is preferred because of its excellent sprayability.
(In the formula, R 1 to R 3 independently represent a hydrocarbon group, and X − represents a monovalent anion.)
In the general formula (A), the hydrocarbon group represented by R 1 to R 3 is not particularly limited, but examples thereof include a linear or branched alkyl group, an unsaturated hydrocarbon group, and an aromatic carbon group. A hydrogen group is mentioned, and an alkyl group having 1 to 6 carbon atoms is preferably excellent in sprayability, more preferably an alkyl group having 1 to 3 carbon atoms such as a methyl group, an ethyl group, an n-propyl group, and an isopropyl group. Is more preferable. Similarly, the general formula (A), X - as the monovalent anion represented by is not particularly limited, for example, fluorine ion, a bromine ion, a chlorine ion, include halogen ions such as iodine ions, Chlorine ions are preferred because of their excellent sprayability. Moreover, you may use a cationizing agent individually or in combination of 2 or more types.
本発明の噴霧用容器詰め液状化粧料に用いるカチオン化ヒアルロン酸及び/又はその塩は、下記一般式(B)で表される構造が好ましい。
(式中、R4〜R9は独立して、水素原子又は第四級アンモニウム基含有基を表す。ただし、R4〜R9がいずれも水素原子を表す場合を除く。)
上記一般式(B)において、R4〜R9で表される第四級アンモニウム基含有基としては、例えば、上記一般式(A)で表される基が挙げられる。
The structure represented by the following general formula (B) is preferable for the cationized hyaluronic acid and / or salt thereof used in the container-packed liquid cosmetic of the present invention.
(In the formula, R 4 to R 9 independently represent a hydrogen atom or a quaternary ammonium group-containing group, except that R 4 to R 9 all represent a hydrogen atom.)
In the general formula (B), examples of the quaternary ammonium group-containing group represented by R 4 to R 9 include a group represented by the general formula (A).
本発明の噴霧用容器詰め液状化粧料に用いるカチオン化ヒアルロン酸及び/又はその塩のカチオン化度(第四級アンモニウム基含有基の置換度)は、まず、セミミクロケルダール法により、原料ヒアルロン酸ナトリウムとカチオン化ヒアルロン酸の窒素含有率を求め、この窒素含有率の増加分に基づいて、下記計算式から算出することにより得ることができる。
例えば、上記一般式(A)において、R1〜R3が全てメチル基でありX−が塩素である第四級アンモニウム基含有基が、ヒアルロン酸ナトリウムに結合したカチオン化ヒアルロン酸ナトリウムのカチオン化度は、以下の方法により求めることができる。
原料ヒアルロン酸ナトリウムの窒素含有率NN(%)、カチオン化度(x)のカチオン化ヒアルロン酸の窒素含有率NS(%)とすると、窒素含有率の増加分(NS―NN)とカチオン化度(x)の関係は次の式で表すことができる。
NS―NN(%)
=[窒素の原子量×x/(カチオン化ヒアルロン酸ナトリウムの二糖単位の分子量)]×100
=[14x/{原料ヒアルロン酸ナトリウムの二糖単位の分子量+(第四級アンモニウム基含有基の分子量−ナトリウムの原子量)x}]×100
=[14x/{401.3+(152.5−23)x}]×100
よって、カチオン化度(第四級アンモニウム基含有基の置換度)は、下記式から求めることができる。
カチオン化度(x)=[(NS―NN)×401.3]/[1400−129.5×(NS―NN)]
また、原料ヒアルロン酸が未知であるカチオン化ヒアルロン酸のカチオン化度は、上記式において、純度99%以上のヒアルロン酸ナトリウムを原料ヒアルロン酸ナトリウムとみなし、上記式から求めることができる。
The degree of cationization of the cationized hyaluronic acid and / or salt thereof used in the containerized liquid cosmetic for spraying of the present invention (substitution degree of the quaternary ammonium group-containing group) is first determined by the raw material sodium hyaluronate by the semi-micro Kjeldahl method. And the nitrogen content of the cationized hyaluronic acid can be obtained and calculated from the following formula based on the increase in the nitrogen content.
For example, cationization of cationized sodium hyaluronate in which the quaternary ammonium group-containing group in which R 1 to R 3 are all methyl groups and X − is chlorine is bonded to sodium hyaluronate in the above general formula (A) The degree can be determined by the following method.
When the nitrogen content N N (%) of the raw material sodium hyaluronate and the nitrogen content N S (%) of the cationized hyaluronic acid with the degree of cationization (x) are increased (N S −N N ) And the degree of cationization (x) can be expressed by the following equation.
N S -N N (%)
= [Atomic weight of nitrogen × x / (molecular weight of disaccharide unit of cationized sodium hyaluronate)] × 100
= [14x / {molecular weight of disaccharide unit of raw material sodium hyaluronate + (molecular weight of quaternary ammonium group-containing group-atomic weight of sodium) x}] x 100
= [14x / {401.3+ (152.5-23) x}] * 100
Therefore, the degree of cationization (the degree of substitution of the quaternary ammonium group-containing group) can be determined from the following formula.
Cation degree (x) = [(N S −N N ) × 401.3] / [1400-129.5 × (N S −N N )]
Further, the degree of cationization of cationized hyaluronic acid whose raw material hyaluronic acid is unknown can be obtained from the above formula, considering sodium hyaluronate having a purity of 99% or more as the raw material sodium hyaluronate in the above formula.
本発明の噴霧用容器詰め液状化粧料における上記カチオン化ヒアルロン酸及び/又はその塩の配合量は、0.001〜1%が好ましく、0.001〜0.5%がさらに好ましい。カチオン化ヒアルロン酸及び/又はその塩の配合量が、前記範囲より少ない場合は健康や美容に関する効果の発現が期待できない場合があり、前記範囲より多い場合は噴霧用容器から霧状に噴霧し難く、液滴状に噴射してしまう場合がある。 0.001-1% is preferable and, as for the compounding quantity of the said cationized hyaluronic acid and / or its salt in the container-packed liquid cosmetic of this invention, 0.001-0.5% is further more preferable. If the amount of cationized hyaluronic acid and / or salt thereof is less than the above range, it may not be possible to expect the effects of health and beauty, and if it is more than the above range, it is difficult to spray in a mist form from the spray container. In some cases, liquid droplets are ejected.
本発明の噴霧用容器詰め液状化粧料に用いる容器は、噴霧用容器詰め液状化粧料を霧状に噴射できるものであれば特に限定されないが、噴射ノズルの墳口径が0.1〜2mmの範囲にあり、トリガー式容器、ポンプ式容器、エアゾール容器等の押圧を用いて内容物を噴霧する容器が挙げられる。特に、本発明の噴霧用容器詰め液状化粧料は、エアゾール等の高圧力をかけなくとも容易に噴霧できることから、トリガー式容器又はポンプ式容器が好ましい。噴射ノズルの墳口径が0.1mm未満の場合は、液状化粧料がノズルに詰まってしまう恐れがあり、2mmより大きい場合は、噴射圧が下がり霧状に噴射されない恐れがある。 Although the container used for the container-packed liquid cosmetic for spraying of the present invention is not particularly limited as long as it can spray the container-packed liquid cosmetic for spraying in the form of a mist, the diameter of the injection nozzle is in the range of 0.1 to 2 mm. The container which sprays the content using press, such as a trigger type container, a pump type container, and an aerosol container, is mentioned. In particular, since the container-packed liquid cosmetic of the present invention can be easily sprayed without applying high pressure such as aerosol, a trigger type container or a pump type container is preferable. When the throat diameter of the injection nozzle is less than 0.1 mm, the liquid cosmetic may be clogged with the nozzle, and when it is more than 2 mm, the injection pressure may be lowered and the mist may not be injected.
本発明に用いる原料ヒアルロン酸及び/又はその塩は、鶏冠、臍の緒、眼球、皮膚、軟骨等の生物組織、あるいはストレプトコッカス属の微生物等のヒアルロン酸生産微生物を培養して得られる培養液等を原料として、これらの原料から抽出(さらに必要に応じて精製)して得られるものである。 The raw material hyaluronic acid and / or salt thereof used in the present invention is a raw material such as a culture solution obtained by culturing a biological tissue such as a chicken crown, umbilical cord, eyeball, skin, cartilage, or a hyaluronic acid-producing microorganism such as a microorganism belonging to the genus Streptococcus. As described above, it is obtained by extraction (further purification if necessary) from these raw materials.
本発明に用いる原料ヒアルロン酸及び/又はその塩は、当該粗抽出物及び精製物のいずれを用いてもよいが、精製物、具体的には原料ヒアルロン酸及び/又はその塩の純度が90%(質量比)以上のものが好ましい。原料ヒアルロン酸及び/又はその塩の純度が90%(質量比)未満の場合、健康や美容に関する効果の発現が期待できない場合がある。また、ヒアルロン酸の塩としては、特に限定されないが、薬学上許容しうる塩であることが好ましく、例えば、ナトリウム塩、カリウム塩、カルシウム塩、亜鉛塩、マグネシウム塩、アンモニウム塩等が挙げられる。 The raw material hyaluronic acid and / or salt thereof used in the present invention may be either the crude extract or the purified product, but the purified product, specifically, the purity of the raw material hyaluronic acid and / or salt thereof is 90%. (Mass ratio) or more is preferable. When the purity of the raw material hyaluronic acid and / or its salt is less than 90% (mass ratio), there may be no expectation of the effects on health and beauty. The salt of hyaluronic acid is not particularly limited, but is preferably a pharmaceutically acceptable salt, and examples thereof include sodium salt, potassium salt, calcium salt, zinc salt, magnesium salt, ammonium salt and the like.
本発明に用いる原料ヒアルロン酸及び/又はその塩の平均分子量は、化粧料として用いられるものであれば特に限定されないが、具体的には分子量5万〜250万のものを用いることができる。 The average molecular weight of the raw material hyaluronic acid and / or salt thereof used in the present invention is not particularly limited as long as it is used as a cosmetic, and specifically, those having a molecular weight of 50,000 to 2,500,000 can be used.
本発明に用いるカチオン化剤は、第四級アンモニウム基を有するものであれば特に限定されないが、噴霧用容器からの噴霧のしやすさの点で、上記一般式(A)で表される3−ハロゲノ−2−ヒドロキシプロピルトリアルキルアンモニウムハライドや、2,3−エポキシプロピルトリアルキルアンモニウムハライド(グリシジルトリアルキルアンモニウム塩)が好ましい。また、カチオン化剤は、単独でも二種以上を組み合わせて使用してもよい。 The cationizing agent used in the present invention is not particularly limited as long as it has a quaternary ammonium group, but it is represented by the above general formula (A) in terms of ease of spraying from the spraying container. -Halogeno-2-hydroxypropyltrialkylammonium halide and 2,3-epoxypropyltrialkylammonium halide (glycidyltrialkylammonium salt) are preferable. Moreover, you may use a cationizing agent individually or in combination of 2 or more types.
本発明の噴霧用容器詰め液状化粧料に用いるカチオン化ヒアルロン酸及び/又はその塩は、原料ヒアルロン酸及び/又はその塩を塩基性含水媒体中でカチオン化剤と反応させる工程を含むことが好ましい。上記方法によれば、例えば、原料ヒアルロン酸及び/又はその塩を水に溶解させてカチオン化剤と反応させる場合と比較して、製造工程の効率を高めることができる。 The cationized hyaluronic acid and / or salt thereof used in the spray-packed liquid cosmetic of the present invention preferably includes a step of reacting the raw material hyaluronic acid and / or salt thereof with a cationizing agent in a basic water-containing medium. . According to the said method, the efficiency of a manufacturing process can be improved compared with the case where the raw material hyaluronic acid and / or its salt are dissolved in water and made to react with a cationizing agent, for example.
本発明の噴霧用容器詰め液状化粧料に用いるカチオン化ヒアルロン酸及び/又はその塩の製造方法において、原料ヒアルロン酸及び/又はその塩を塩基性含水媒体中でカチオン化剤と反応させる工程では、原料ヒアルロン酸及び/又はその塩は、塩基性含水媒体中に分散させた状態でカチオン化剤と反応させることが好ましい。ここで、反応条件(時間、温度等)を調整することにより、カチオン化の度合いを調整することができる。 In the method for producing cationized hyaluronic acid and / or salt thereof used in the container-packed liquid cosmetic of the present invention, in the step of reacting raw material hyaluronic acid and / or salt thereof with a cationizing agent in a basic water-containing medium, The raw material hyaluronic acid and / or salt thereof is preferably reacted with a cationizing agent in a state dispersed in a basic water-containing medium. Here, the degree of cationization can be adjusted by adjusting the reaction conditions (time, temperature, etc.).
本実施形態に係る噴霧用容器詰め液状化粧料は、本発明の噴霧用容器詰め液状化粧料の必須原料であるカチオン化ヒアルロン酸及び/又はその塩以外に、本発明の効果を損わない範囲で適宜選択し配合することができる。具体的には、例えば、高級アルコール、多価アルコール、界面活性剤、高分子物質、pH調整剤、金属封鎖剤、酸化防止剤、紫外線吸収剤、防腐剤、抗炎剤、アミノ酸、香料、着色料等を配合しても良く、それらは公知のものを広く使用できる。 The container-packed liquid cosmetic for spraying according to the present embodiment is a range that does not impair the effects of the present invention other than cationized hyaluronic acid and / or a salt thereof, which is an essential raw material for the container-packed liquid cosmetic of the present invention. Can be appropriately selected and blended. Specifically, for example, higher alcohols, polyhydric alcohols, surfactants, polymer substances, pH adjusters, metal sequestering agents, antioxidants, ultraviolet absorbers, preservatives, anti-flame agents, amino acids, perfumes, coloring A material may be blended, and known materials can be widely used.
次に、本発明を以下の実施例、比較例及び試験例に基づき、さらに詳細に説明する。なお、本発明はこれらに限定されるものではない。なお、カチオン化度の測定は上述した方法を用いた。 Next, the present invention will be described in more detail based on the following examples, comparative examples, and test examples. The present invention is not limited to these. The method described above was used for measuring the degree of cationization.
〔実施例1〕(カチオン化ヒアルロン酸及び/又はその塩の調製)
1L容ビーカーに、ヒアルロン酸ナトリウム(平均分子量:約190万)20g、5%水酸化ナトリウム20mL、80%含水エタノール180mL、及びグリシジルトリメチルアンモニウムクロリド(GTA(有効成分約80%、水分約20%))30mLを添加し、撹拌子を用いて撹拌しながら、40℃で1時間反応させた。
次に、デカンテーションにより液を除去して、固形物(カチオン化ヒアルロン酸を含む)を得た。
次いで、食塩水400mLを加え、固形物を溶解させた。固形物が完全に溶解したことを確認した後、エタノール600mLを添加して、カチオン化ヒアルロン酸及び/又はその塩を沈殿させた。デカンテーションにより液を除去した後、80%含水エタノール500mLを添加して15分間撹拌し、さらに、含水エタノールをデカンテーションにより除去して沈殿物を得た。この操作を3回繰り返し、沈殿物に残存するカチオン化剤(GTA)及び食塩を除去した。
次いで、遠心分離処理を行うことにより含水エタノールをさらに除去した後、真空乾燥機を用いて、60℃にて減圧で5時間加熱乾燥を行った。
これにより、白色粉末のカチオン化ヒアルロン酸及び/又はその塩20.5gを得た。得られたカチオン化ヒアルロン酸及び/又はその塩をイオン交換水に溶解し0.25%試料水溶液を調製した。なお、得られたカチオン化ヒアルロン酸及び/又はその塩の窒素含有率を測定し、上述の計算式によって求めたカチオン化度は0.27であった。
[Example 1] (Preparation of cationized hyaluronic acid and / or salt thereof)
In a 1 L beaker, 20 g of sodium hyaluronate (average molecular weight: about 1.9 million), 20 mL of 5% sodium hydroxide, 180 mL of 80% aqueous ethanol, and glycidyltrimethylammonium chloride (GTA (active ingredient about 80%, moisture about 20%) ) 30 mL was added and reacted for 1 hour at 40 ° C. with stirring using a stir bar.
Next, the liquid was removed by decantation to obtain a solid (including cationized hyaluronic acid).
Next, 400 mL of brine was added to dissolve the solid. After confirming that the solid was completely dissolved, 600 mL of ethanol was added to precipitate cationized hyaluronic acid and / or a salt thereof. After removing the liquid by decantation, 500 mL of 80% aqueous ethanol was added and stirred for 15 minutes, and the aqueous ethanol was then removed by decantation to obtain a precipitate. This operation was repeated three times to remove the cationizing agent (GTA) and salt remaining in the precipitate.
Next, the water-containing ethanol was further removed by performing a centrifugal separation treatment, followed by heat drying at 60 ° C. under reduced pressure for 5 hours using a vacuum dryer.
As a result, 20.5 g of cationized hyaluronic acid and / or a salt thereof was obtained as a white powder. The obtained cationized hyaluronic acid and / or salt thereof was dissolved in ion-exchanged water to prepare a 0.25% sample aqueous solution. In addition, the nitrogen content rate of the obtained cationized hyaluronic acid and / or its salt was measured, and the cationization degree calculated | required by the above-mentioned formula was 0.27.
〔実施例2〕(カチオン化ヒアルロン酸及び/又はその塩の調製)
1L容ビーカーに、ヒアルロン酸ナトリウム(平均分子量:約190万)20g、5%水酸化ナトリウム20mL、65%含水エタノール180mL、およびグリシジルトリメチルアンモニウムクロリド(GTA(有効成分約80%、水分約20%))30mLを添加し、撹拌子を用いて撹拌しながら、60℃で1時間反応させた。
次に、デカンテーションにより液を除去して、固形物(カチオン化ヒアルロン酸及び/又はその塩を含む)を得た。
次いで、食塩水400mLを加え、固形物を溶解させた。固形物が完全に溶解したことを確認した後、エタノール600mLを添加して、カチオン化ヒアルロン酸及び/又はその塩を沈殿させた。デカンテーションにより液を除去した後、80%含水エタノール500mLを添加して15分間撹拌し、さらに、含水エタノールをデカンテーションにより除去して沈殿物を得た。この操作を3回繰り返し、沈殿物に残存するカチオン化剤(GTA)および食塩を除去した。
次いで、遠心分離処理を行うことにより含水エタノールをさらに除去した後、真空乾燥機を用いて、60℃にて減圧で5時間加熱乾燥を行った。
これにより、白色粉末のカチオン化ヒアルロン酸及び/又はその塩21.3gを得た。得られたカチオン化ヒアルロン酸及び/又はその塩をイオン交換水に溶解し0.25%試料水溶液を調製した。なお、得られたカチオン化ヒアルロン酸及び/又はその塩の窒素含有率を測定し、上述の計算式によって求めたカチオン化度は0.48であった。
[Example 2] (Preparation of cationized hyaluronic acid and / or salt thereof)
In a 1 L beaker, 20 g of sodium hyaluronate (average molecular weight: about 1.9 million), 20 mL of 5% sodium hydroxide, 180 mL of 65% aqueous ethanol, and glycidyltrimethylammonium chloride (GTA (active ingredient about 80%, moisture about 20%) ) 30 mL was added and reacted at 60 ° C. for 1 hour with stirring using a stir bar.
Next, the liquid was removed by decantation to obtain a solid (containing cationized hyaluronic acid and / or a salt thereof).
Next, 400 mL of brine was added to dissolve the solid. After confirming that the solid was completely dissolved, 600 mL of ethanol was added to precipitate cationized hyaluronic acid and / or a salt thereof. After removing the liquid by decantation, 500 mL of 80% aqueous ethanol was added and stirred for 15 minutes, and the aqueous ethanol was then removed by decantation to obtain a precipitate. This operation was repeated three times to remove the cationizing agent (GTA) and sodium chloride remaining in the precipitate.
Next, the water-containing ethanol was further removed by performing a centrifugal separation treatment, followed by heat drying at 60 ° C. under reduced pressure for 5 hours using a vacuum dryer.
As a result, 21.3 g of cationized hyaluronic acid and / or a salt thereof as white powder was obtained. The obtained cationized hyaluronic acid and / or salt thereof was dissolved in ion-exchanged water to prepare a 0.25% sample aqueous solution. In addition, the nitrogen content rate of the obtained cationized hyaluronic acid and / or its salt was measured, and the cationization degree calculated | required by the above-mentioned formula was 0.48.
〔実施例3〕(カチオン化ヒアルロン酸及び/又はその塩の調製)
実施例2のカチオン化ヒアルロン酸及び/又はその塩の調製方法において、反応温度を50℃とした以外は、実施例2のカチオン化ヒアルロン酸及び/又はその塩の調製方法と同様にして、実施例3のカチオン化ヒアルロン酸及び/又はその塩を調製した。
これにより、白色粉末のカチオン化ヒアルロン酸及び/又はその塩20.2gを得た。得られたカチオン化ヒアルロン酸及び/又はその塩をイオン交換水に溶解し0.25%試料水溶液を調製した。なお、得られたカチオン化ヒアルロン酸及び/又はその塩の窒素含有率を測定し、上述の計算式によって求めたカチオン化度は0.33であった。
[Example 3] (Preparation of cationized hyaluronic acid and / or salt thereof)
In the preparation method of the cationized hyaluronic acid and / or salt thereof in Example 2, the reaction was carried out in the same manner as in the preparation method of the cationized hyaluronic acid and / or salt thereof in Example 2, except that the reaction temperature was 50 ° C. The cationized hyaluronic acid and / or salt thereof of Example 3 was prepared.
As a result, 20.2 g of cationized hyaluronic acid and / or a salt thereof as white powder was obtained. The obtained cationized hyaluronic acid and / or salt thereof was dissolved in ion-exchanged water to prepare a 0.25% sample aqueous solution. In addition, the nitrogen content rate of the obtained cationized hyaluronic acid and / or its salt was measured, and the cationization degree calculated | required by the above-mentioned calculation formula was 0.33.
〔実施例4〕(カチオン化ヒアルロン酸及び/又はその塩の調製)
実施例2のカチオン化ヒアルロン酸及び/又はその塩の調製方法において、反応温度を30℃とし、反応時間を0.1時間とした以外は、実施例2のカチオン化ヒアルロン酸及び/又はその塩の調製方法と同様にして、実施例4のカチオン化ヒアルロン酸及び/又はその塩を調製した。
これにより、白色粉末のカチオン化ヒアルロン酸及び/又はその塩19.6gを得た。得られたカチオン化ヒアルロン酸及び/又はその塩をイオン交換水に溶解し0.25%試料水溶液を調製した。なお、得られたカチオン化ヒアルロン酸及び/又はその塩の窒素含有率を測定し、上述の計算式によって求めたカチオン化度は0.16であった。
[Example 4] (Preparation of cationized hyaluronic acid and / or salt thereof)
The cationized hyaluronic acid and / or salt thereof of Example 2 except that the reaction temperature was 30 ° C. and the reaction time was 0.1 hour in the preparation method of the cationized hyaluronic acid and / or salt thereof of Example 2. The cationized hyaluronic acid and / or salt thereof of Example 4 was prepared in the same manner as in the preparation method.
As a result, 19.6 g of cationized hyaluronic acid and / or a salt thereof as white powder was obtained. The obtained cationized hyaluronic acid and / or salt thereof was dissolved in ion-exchanged water to prepare a 0.25% sample aqueous solution. In addition, the nitrogen content rate of the obtained cationized hyaluronic acid and / or its salt was measured, and the cationization degree calculated | required by the above-mentioned formula was 0.16.
〔比較例1〕(カチオン化ヒアルロン酸及び/又はその塩の調製)
実施例2のカチオン化ヒアルロン酸及び/又はその塩の調製方法において、5%水酸化ナトリウムを12mL、65%含水エタノールを190mL、およびグリシジルトリメチルアンモニウムクロリド(GTA(有効成分約80%、水分約20%))を3mLとする以外は、実施例2のカチオン化ヒアルロン酸及び/又はその塩の調製方法と同様にして、比較例1のカチオン化ヒアルロン酸及び/又はその塩を調製した。
これにより、白色粉末のカチオン化ヒアルロン酸及び/又はその塩19.7gを得た。得られたカチオン化ヒアルロン酸及び/又はその塩をイオン交換水に溶解し0.25%試料水溶液を調製した。なお、得られたカチオン化ヒアルロン酸及び/又はその塩の窒素含有率を測定し、上述の計算式によって求めたカチオン化度は0.08であった。
[Comparative Example 1] (Preparation of cationized hyaluronic acid and / or salt thereof)
In the method for preparing the cationized hyaluronic acid and / or salt thereof of Example 2, 12 mL of 5% sodium hydroxide, 190 mL of 65% aqueous ethanol, and glycidyltrimethylammonium chloride (GTA (active ingredient about 80%, moisture about 20) %)) Was changed to 3 mL, and the cationized hyaluronic acid and / or salt thereof of Comparative Example 1 was prepared in the same manner as the preparation method of the cationized hyaluronic acid and / or salt thereof of Example 2.
As a result, 19.7 g of cationized hyaluronic acid and / or a salt thereof was obtained as a white powder. The obtained cationized hyaluronic acid and / or salt thereof was dissolved in ion-exchanged water to prepare a 0.25% sample aqueous solution. In addition, the nitrogen content rate of the obtained cationized hyaluronic acid and / or its salt was measured, and the cationization degree calculated | required by the above-mentioned calculation formula was 0.08.
〔試験例1〕
カチオン化度による噴霧用容器からの噴霧性を調べるため、実施例1〜4及び比較例1の0.25%試料水溶液各40mLを市販の50mL容ポンプ式噴霧容器(噴口径0.3mm)に詰め、品温25℃で1回の噴射量が約10mLとなるように噴射し、下記の判断基準で噴霧用容器からの噴霧性を評価した。
[Test Example 1]
In order to investigate the sprayability from the container for spraying according to the degree of cationization, 40 mL of each of the 0.25% sample aqueous solutions of Examples 1 to 4 and Comparative Example 1 was put into a commercially available 50 mL pump spray container (nozzle diameter 0.3 mm). The product was sprayed at a product temperature of 25 ° C. so that the injection amount per injection was about 10 mL, and the sprayability from the spray container was evaluated according to the following criteria.
噴霧用容器からの噴霧性の評価は、外観の目視検査により確認し、霧状の場合をA、ほぼ霧状の場合をB、液滴状の場合をCとした。 The evaluation of sprayability from the container for spraying was confirmed by visual inspection of the appearance, and the case of mist was A, the case of almost mist was B, and the case of droplet was C.
表1に示すとおり、カチオン化度0.15〜0.6の場合、噴霧用容器からほぼ霧状に噴射された(実施例1〜4)。特に、カチオン化度0.2〜0.6の場合、霧状に噴射され非常に好ましい性状を示した(実施例1〜3)。一方、カチオン化度0.15未満の場合は、噴霧用容器から液滴状に噴射され、噴霧用容器詰め液状化粧料としての適性を損ねていた(比較例1)。 As shown in Table 1, when the degree of cationization was 0.15 to 0.6, the mist was sprayed from the spray container in a substantially mist form (Examples 1 to 4). In particular, when the degree of cationization was 0.2 to 0.6, it was sprayed in a mist form and exhibited very favorable properties (Examples 1 to 3). On the other hand, when the degree of cationization was less than 0.15, the liquid was sprayed from the spray container in the form of droplets, and the suitability as a spray container-packed liquid cosmetic was impaired (Comparative Example 1).
〔実施例5〕
定法に従い、下記処方にて実施例1で得られたカチオン化ヒアルロン酸及び/又はその塩を配合した化粧水を調製した。調製した化粧水30mLを市販の50mL容ポンプ式噴霧容器(噴口径0.3mm)に詰め、品温25℃で、1回の噴射量が約10mLとなるように噴射し、試験例1の判断基準で噴霧用容器からの噴霧性を評価した。
カチオン化ヒアルロン酸及び/又はその塩(実施例1) 0.5W/V%
オクタン酸セチル 0.3W/V%
メトキシ桂皮酸オクチル 0.15W/V%
酢酸トコフェロール 0.1W/V%
EMALEX RWIS-158 2.0W/V%
(イソステアリン酸PEG-58水添ヒマシ油)
Eldew PS-306 0.5W/V%
(ラウロイルグルタミン酸ジ(オクチルドデシル/フィトステリル/ベヘニル))
ブチルパラベン 0.1W/V%
メチルパラベン 0.2W/V%
1,3−ブチレングリコール 5.0W/V%
精製水 残量
本試験例によれば、実施例1で得られたカチオン化ヒアルロン酸及び/又はその塩を配合した噴霧用容器詰め化粧水は、ポンプ式噴霧容器に押圧を与えることにより霧状に噴射することができた。
Example 5
In accordance with the usual method, the lotion which mix | blended the cationized hyaluronic acid and / or its salt obtained in Example 1 with the following prescription was prepared. 30 ml of the prepared lotion is filled in a commercially available 50 ml pump-type spray container (nozzle diameter 0.3 mm), and sprayed at a product temperature of 25 ° C. so that a single spray amount is about 10 ml. The sprayability from the container for spraying was evaluated on the basis.
Cationized hyaluronic acid and / or salt thereof (Example 1) 0.5 W / V%
Cetyl octoate 0.3W / V%
Octyl methoxycinnamate 0.15W / V%
Tocopherol acetate 0.1W / V%
EMALEX RWIS-158 2.0W / V%
(PEG-58 isostearic acid hydrogenated castor oil)
Eldew PS-306 0.5W / V%
(Lauroyl glutamate di (octyldodecyl / phytosteryl / behenyl))
Butylparaben 0.1W / V%
Methylparaben 0.2W / V%
1,3-butylene glycol 5.0 W / V%
Purified water remaining amount According to this test example, the container-packed lotion for spraying containing the cationized hyaluronic acid and / or salt thereof obtained in Example 1 is sprayed by applying pressure to the pump spray container. Was able to be injected.
〔実施例6〕
定法に従い、下記処方にて実施例2で得られたカチオン化ヒアルロン酸及び/又はその塩を配合したアフターサンローションを調製した。調製したアフターサンローション150mLを市販の200mL容トリガー式噴霧容器(噴口径0.4mm)に詰め、品温25℃で、1回の噴射量が約10mLとなるように噴射し、試験例1の判断基準で噴霧用容器からの噴霧性を評価した。
カチオン化ヒアルロン酸及び/又はその塩(実施例2) 0.4W/V%
エタノール 11.04W/V%
BG 4.16W/V%
オウゴンエキス 適量
ステアリルアルコール 0.72W/V%
アボカド油 0.72W/V%
ステアリン酸 0.02W/V%
オリザノール 適量
ポリソルベート 0.23W/V%
PPG−6デシルテトラデセス−20 0.2W/V%
オクトキシノール−3 0.08W/V%
メチルパラベン 0.14W/V%
プロピルパラベン 0.07W/V%
カルボマー 0.13W/V%
PVP 適量
水酸化カリウム 0.04W/V%
EDTA−2ナトリウム 0.01W/V%
トコフェロール 適量
精製水 残量
本試験例によれば、実施例2で得られたカチオン化ヒアルロン酸及び/又はその塩を配合した噴霧用容器詰めアフターサンローションは、トリガー式噴霧容器に押圧を与えることにより霧状に噴射することができた。
Example 6
According to a conventional method, an after sun lotion was prepared by blending the cationized hyaluronic acid and / or salt thereof obtained in Example 2 with the following formulation. 150 mL of the prepared after sun lotion was packed into a commercially available 200 mL trigger spray container (0.4 mm nozzle diameter), and sprayed at a product temperature of 25 ° C. so that the injection amount per injection was about 10 mL. The sprayability from the container for spraying was evaluated according to the judgment criteria.
Cationized hyaluronic acid and / or salt thereof (Example 2) 0.4 W / V%
Ethanol 11.04W / V%
BG 4.16W / V%
Ougon extract appropriate amount stearyl alcohol 0.72W / V%
Avocado oil 0.72 W / V%
Stearic acid 0.02W / V%
Oryzanol appropriate amount polysorbate 0.23W / V%
PPG-6decyltetradeceth-20 0.2W / V%
Octoxynol-3 0.08W / V%
Methylparaben 0.14W / V%
Propylparaben 0.07W / V%
Carbomer 0.13W / V%
PVP proper amount potassium hydroxide 0.04W / V%
EDTA-2 sodium 0.01W / V%
Tocopherol Appropriate amount of purified water Remaining amount According to this test example, the after-packed after-sun lotion for spraying containing the cationized hyaluronic acid and / or salt thereof obtained in Example 2 gives pressure to the trigger type spraying container. Could be sprayed in the form of a mist.
以上の結果より、第四級アンモニウム基含有基を有し、カチオン化度が0.15〜0.6であるカチオン化ヒアルロン酸及び/又はその塩を配合する噴霧用容器詰め液状化粧料は、噴霧用容器からの噴霧性に優れているといえる。 From the above results, a containerized liquid cosmetic for spraying containing a cationized hyaluronic acid having a quaternary ammonium group-containing group and a cationization degree of 0.15 to 0.6 and / or a salt thereof, It can be said that the sprayability from the container for spraying is excellent.
Claims (3)
(式中、R1〜R3は独立して炭化水素基を表し、X−は1価の陰イオンを表す。) The container-packed liquid cosmetic for spraying according to claim 1, wherein the quaternary ammonium group-containing group is represented by the following general formula (A).
(In the formula, R 1 to R 3 independently represent a hydrocarbon group, and X − represents a monovalent anion.)
(式中、R4〜R9は独立して、水素原子又は第四級アンモニウム基含有基を表す。ただし、R4〜R9がいずれも水素原子を表す場合を除く。) The containerized liquid cosmetic for spraying according to claim 1 or 2, wherein the cationized hyaluronic acid and / or a salt thereof is represented by a repeating structural unit of the following general formula (B).
(In the formula, R 4 to R 9 independently represent a hydrogen atom or a quaternary ammonium group-containing group, except that R 4 to R 9 all represent a hydrogen atom.)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008190210A JP2010024207A (en) | 2008-07-23 | 2008-07-23 | Liquid cosmetic filled in spray container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008190210A JP2010024207A (en) | 2008-07-23 | 2008-07-23 | Liquid cosmetic filled in spray container |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2010024207A true JP2010024207A (en) | 2010-02-04 |
Family
ID=41730351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008190210A Pending JP2010024207A (en) | 2008-07-23 | 2008-07-23 | Liquid cosmetic filled in spray container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2010024207A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014125436A (en) * | 2012-12-25 | 2014-07-07 | Kracie Home Products Ltd | Foamy skin lotion |
KR20240144098A (en) | 2022-01-31 | 2024-10-02 | 가부시키가이샤 미르본 | Compositions for hair and/or skin, methods for treating hair and/or skin, and devices for hair and/or skin |
-
2008
- 2008-07-23 JP JP2008190210A patent/JP2010024207A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014125436A (en) * | 2012-12-25 | 2014-07-07 | Kracie Home Products Ltd | Foamy skin lotion |
KR20240144098A (en) | 2022-01-31 | 2024-10-02 | 가부시키가이샤 미르본 | Compositions for hair and/or skin, methods for treating hair and/or skin, and devices for hair and/or skin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5241708B2 (en) | Cationized hyaluronic acid and / or salt thereof, method for producing the same, and hair modifying agent, cuticle restorative agent, skin modifying agent and cosmetics using the same | |
EP4117618B1 (en) | Surfactants for personal care and cosmetic products | |
KR20070043449A (en) | Nano emulsion skin aging prevention cosmetics composition | |
JP5989226B2 (en) | Gel-like composition for skin | |
WO1996005233A1 (en) | Low-molecular-weight acetylated hyaluronic acid, emollient, and processes for producing and purifying the acid | |
JP2008285421A (en) | Hair modification penetrant and cosmetic for hair using the same | |
JP5876296B2 (en) | Gel-like composition | |
TW201517912A (en) | Crosslinked product of carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof, and method for producing same | |
TW200817040A (en) | Emulsion composition with good feeling of use | |
BR112019001841B1 (en) | FORMULATION FOR BODY WASHING | |
KR102026365B1 (en) | Cosmetic composition comprising uridine and activation complex | |
KR102610937B1 (en) | Crosslinked hyaluronic acid compositions and method of producing the same | |
JP2013006836A (en) | Skin barrier function improver | |
JP2017043588A (en) | Kit for skin external preparation | |
JP2010024207A (en) | Liquid cosmetic filled in spray container | |
JP5734536B1 (en) | Carboxymethyl group-containing modified hyaluronic acid and / or a salt thereof and a method for producing the same | |
JP4113614B2 (en) | Gel-like product manufacturing method | |
JP7061111B2 (en) | Personal care composition | |
JP6172507B2 (en) | Acyl carboxymethyl cellulose and cosmetics containing acyl carboxymethyl cellulose | |
JP2012240993A (en) | Skin elasticity improver | |
JP2004075635A (en) | Moisturizing agent and external preparation for skin | |
JP2003238380A (en) | Cosmetic | |
JPH05301812A (en) | Skin external preparation | |
JP5683410B2 (en) | Cosmetics | |
JP2016199515A (en) | Emulsion cosmetic |